Rock Springs Capital Management’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-307,699
Closed -$26.1M 144
2019
Q4
$26.1M Sell
307,699
-492,301
-62% -$32.8M 0.83% 50
2019
Q3
$40M Hold
800,000
1.59% 15
2019
Q2
$29.2M Buy
800,000
+70,600
+10% +$2.3M 1.06% 29
2019
Q1
$20.4M Buy
729,400
+2,500
+0.3% +$58.9K 0.79% 47
2018
Q4
$13.9M Buy
726,900
+36,900
+5% +$858K 0.66% 50
2018
Q3
$20.6M Hold
690,000
0.75% 44
2018
Q2
$25.3M Hold
690,000
0.97% 32
2018
Q1
$22.7M Hold
690,000
0.97% 35
2017
Q4
$18.9M Hold
690,000
0.86% 38
2017
Q3
$25.6M Sell
690,000
-4,446
-0.6% -$164K 1.18% 24
2017
Q2
$26.4M Sell
694,446
-5,554
-0.8% -$247K 1.33% 21
2017
Q1
$34.2M Buy
700,000
+500
+0.1% +$22.8K 1.98% 11
2016
Q4
$23.7M Buy
699,500
+18,500
+3% +$656K 1.59% 21
2016
Q3
$25.7M Buy
681,000
+500
+0.1% +$18.8K 1.61% 20
2016
Q2
$22.9M Buy
680,500
+48,500
+8% +$1.71M 1.69% 17
2016
Q1
$20.1M Buy
632,000
+7,000
+1% +$229K 1.68% 16
2015
Q4
$23.3M Buy
625,000
+30,000
+5% +$1.13M 1.77% 16
2015
Q3
$22.6M Buy
595,000
+249,500
+72% +$8.76M 1.83% 11
2015
Q2
$9.88M Buy
345,500
+45,500
+15% +$1.27M 0.72% 45
2015
Q1
$8.41M Buy
300,000
+53,700
+22% +$1.51M 0.79% 43
2014
Q4
$6.82M Buy
246,300
+98,050
+66% +$2.43M 0.8% 47
2014
Q3
$3.31M Buy
148,250
+13,150
+10% +$334K 0.51% 62
2014
Q2
$3.93M Buy
135,100
+15,100
+13% +$403K 0.7% 53
2014
Q1
$3.41M Buy
120,000
+87,500
+269% +$2.9M 0.79% 40
2013
Q4
$1.25M Buy
+32,500
New +$1.16M 0.45% 55

Other funds holding MDCO

Rock Springs Capital Management's MDCO Position: Q1 2020 in Review

Rock Springs Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 307,699 shares — an estimated $26.1M sold.

Rock Springs Capital Management first reported a position in MDCO in Q4 2013 and held it in 25 quarters. The position peaked at $40M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Rock Springs Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Rock Springs Capital Management sold 307,699 Medicines Co shares in Q1 2020, an estimated $26.1M.
  • Rock Springs Capital Management first reported a position in Medicines Co in Q4 2013 and held it in 25 quarters.
  • Rock Springs Capital Management's Medicines Co position peaked at $40M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Rock Springs Capital Management's 13F filing for Q1 2020, filed 15 May 2020.